Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D

被引:495
作者
Liu, Shiguang
Tang, Wen
Zhou, Jianping
Stubbs, Jason R.
Luo, Qiang
Pi, Min
Quarles, L. Darryl
机构
[1] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66160 USA
[2] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66160 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2006年 / 17卷 / 05期
关键词
D O I
10.1681/ASN.2005111185
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The regulation of the phosphaturic factor fibroblast growth factor 23 (FGF23) is not well understood. It was found that administration of 1,25-dihydroxyvitamin D-3 (1,25[OH](2)D-3) to mice rapidly increased serum FGF23 concentrations from a basal level of 90.6 +/- 8.1 to 213.8 +/- 14.6 pg/ml at 8 h (mean +/- SEM; P < 0.01) and resulted in a four-fold increase in FGF23 transcripts in bone, the predominate site of FGF23 expression. In the Hyp-mouse homologue of X-linked hypophosphatemic rickets, administration of 1,25(OH)(2)D-3 further increased circulating FGF23 levels. In Gcm2 null mice, low 1,25(OH)2D3 levels were associated with a three-fold reduction in FGF23 levels that were increased by administration of 1,25(OH)2D3. In osteoblast cell cultures, 1,25(OH)2D3 but not calcium, phosphate, or parathyroid hormone stimulated FGF23 mRNA levels and resulted in a dose-dependent increase in FGF23 promoter activity. Overexpression of a dominant negative vitamin D receptor inhibited 1,25(OH)2D3 stimulation of FGF23 promoter activity, and mutagenesis of the FGF23 promoter identified a vitamin D-responsive element (-1180 GGAACTcagTAACCT -1156) that is responsible for the vitamin D effects. These data suggest that 1,25(OH)2D3 is an important regulator of FGF23 production by osteoblasts in bone. The physiologic role of FGF23 may be to act as a counterregulatory phosphaturic hormone to maintain phosphate homeostasis in response to vitamin D.
引用
收藏
页码:1305 / 1315
页数:11
相关论文
共 46 条
[1]   Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders [J].
Bai, XY ;
Miao, DS ;
Li, JR ;
Goltzman, D ;
Karaplis, AC .
ENDOCRINOLOGY, 2004, 145 (11) :5269-5279
[2]   An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia [J].
Benet-Pagès, A ;
Orlik, P ;
Strom, TM ;
Lorenz-Depiereux, B .
HUMAN MOLECULAR GENETICS, 2005, 14 (03) :385-390
[3]   FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate [J].
Bowe, AE ;
Finnegan, R ;
de Beur, SMJ ;
Cho, J ;
Levine, MA ;
Kumar, R ;
Schiavi, SC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 284 (04) :977-981
[4]   1,25-(OH)2D3 down-regulates expression of Phex, a marker of the mature osteoblast [J].
Ecarot, B ;
Desbarats, M .
ENDOCRINOLOGY, 1999, 140 (03) :1192-1199
[5]   Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men [J].
Ferrari, SL ;
Bonjour, JP ;
Rizzoli, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03) :1519-1524
[6]   RESISTANCE TO THE PHOSPHATURIC AND CALCEMIC ACTIONS OF PARATHYROID-HORMONE DURING PHOSPHATE DEPLETION - PREVENTION BY 1,25-DIHYDROXYVITAMIN-D3 [J].
GLOOR, HJ ;
BONJOUR, JP ;
CAVERZASIO, J ;
FLEISCH, H .
JOURNAL OF CLINICAL INVESTIGATION, 1979, 63 (03) :371-377
[7]   Genetic ablation of parathyroid glands reveals another source of parathyroid hormone [J].
Günther, T ;
Chen, ZF ;
Kim, JS ;
Priemel, M ;
Rueger, JM ;
Amling, M ;
Moseley, JM ;
Martin, TJ ;
Anderson, DJ ;
Karsenty, G .
NATURE, 2000, 406 (6792) :199-203
[8]   Analysis of recombinant Phex:: an endopeptidase in search of a substrate [J].
Guo, R ;
Liu, SG ;
Spurney, RF ;
Quarles, LD .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 281 (04) :E837-E847
[9]   FGF-23 is elevated by chronic hyperphosphatemia [J].
Gupta, A ;
Winer, K ;
Econs, MJ ;
Marx, SJ ;
Collins, MT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (09) :4489-4492
[10]   1,25-dihydroxyvitamin D3 down-regulation of PHEX gene expression is mediated by apparent repression of a 110 kDa transfactor that binds to a polyadenine element in the promoter [J].
Hines, ER ;
Kolek, OI ;
Jones, MD ;
Serey, SH ;
Sirjani, NB ;
Kiela, PR ;
Jurutka, PW ;
Haussler, MR ;
Collins, JF ;
Ghishan, FK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (45) :46406-46414